Drugs / Carbamazepin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04783753 | Nov 2020 → Jun 2021 | hepatitis B virus infection | Enanta Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05697614 | Mar → May 2023 | epilepsy | Dr Cipto Mangunkusumo General Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carbamazepin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05697614 ↗ |